Table 3 ATS scale and ΔATS scale of each group during and after FGF-2 treatment in a clinical trial

From: The role of FGF-2 in smoke-induced emphysema and the therapeutic potential of recombinant FGF-2 in patients with COPD

 

ATS scale

ΔATS scale

Control

FGF-2

Control

FGF-2

T1

2.2 ± 0.4

2.2 ± 0.8

0.0 ± 0.0

0.0 ± 0.0

T7

1.6 ± 1.1

2.2 ± 0.8

−0.6 ± 0.9

0.0 ± 0.0

T15

1.8 ± 0.8

2.0 ± 0.0

−0.4 ± 0.5

−0.2 ± 0.8

A4

1.4 ± 0.9

1.5 ± 0.8

−0.8 ± 0.4

−0.7 ± 0.8

  1. ATS American Thoracic Society, FGF-2 fibroblast growth factor-2, T1 1 day of treatment, T7 7 days of treatment, T15 15 days of treatment, A4 after 4 weeks of treatment.